![Frontiers | Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies Frontiers | Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies](https://www.frontiersin.org/files/MyHome%20Article%20Library/917151/917151_Thumb_400.jpg)
Frontiers | Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies
![Time to reimbursement and negotiation condition in Italy for drugs approved by the European Medicines Agency during the period 2014-2019 Time to reimbursement and negotiation condition in Italy for drugs approved by the European Medicines Agency during the period 2014-2019](https://journals.aboutscience.eu/index.php/aboutopen/article/download/2184/2221/6054/img03.jpg)
Time to reimbursement and negotiation condition in Italy for drugs approved by the European Medicines Agency during the period 2014-2019
![Farmaci innovativi a base di RNAi. Prada (Intexo): “Quando la ricerca si traduce in vera innovatività” Farmaci innovativi a base di RNAi. Prada (Intexo): “Quando la ricerca si traduce in vera innovatività”](https://www.true-news.it/wp-content/uploads/2022/04/mariangela-intexo.jpg)